Patents
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
05/2000
05/10/2000CN1252795A 4,1-benzoxazepines, their analogues,and their use as somatostatin agonists
05/09/2000US6060586 Ureins derived from alpha, omega-diamono acids and process for their preparation
05/09/2000US6060071 Ectoin and ectoin derivatives as moisturizers in cosmetics
05/04/2000WO2000024400A1 Use of optically pure (r)-tofisopam for treating and preventing anxiety disorders and composition thereof
05/04/2000CA2348281A1 Use of optically pure (r)-tofisopam for treating and preventing anxiety disorders and composition thereof
05/03/2000CN1052000C Preparation of alkylimidazolidone (meth) acrylates
05/03/2000CN1051999C Preparation of alkylimidazolidine (meth) acrylate (S)
04/2000
04/27/2000WO2000023487A1 Amino-ketone solid support templates
04/27/2000WO2000023428A1 1,5-benzodiazepine compounds, process for producing the same, and medicine
04/27/2000CA2347938A1 1,5-benzodiazepine compounds, their production and use
04/27/2000CA2347243A1 Amino-ketone solid support templates
04/25/2000US6054597 Reacting the corresponding dimethyl ester with reducing agent; then hydrazine
04/25/2000US6054457 Benzamide derivatives and their use as vasopressin antagonists
04/20/2000DE19949352A1 Heterocyclic alkoxyamine polymerization composition useful as regulator in free-radical polymerization to obtain low-polydispersity polymeric resins
04/18/2000CA2087604C Diamine compounds and cerebral protective drugs containing the same
04/16/2000CA2286375A1 Heterocyclic alkoxyamines as regulators in controlled radical polymerization processes
04/05/2000CN1051079C Benzodiazepine derivs. their preparation method and pharmaceutical composition contg. same
03/2000
03/29/2000CN1050835C 1,5-benzodiazepine derivatives and its preparation process and use in medicine
03/28/2000US6043358 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
03/22/2000EP0986585A1 Use of ylides of phosphorus as slightly nuceophilic strong bases
03/22/2000EP0830349B1 Method for preparing n, n'-disubstitued cyclic ureas
03/22/2000CN1248250A Novel 1,4-diazacycloheptane derivatives and their use in hair oxidation dyes
03/21/2000US6040303 7-phenyl-1, 4-diazepane compounds, process for their preparation, and pharmaceutical compositions containing them
03/16/2000WO2000014073A1 Benzodiazepinone derivatives, preparation method and intermediates therefor, use as medicines and compositions
03/16/2000WO2000014063A1 Therapeutic compounds and methods
03/16/2000CA2342858A1 Method of screening compounds useful in the treatment of a desease caused by or exacerbated by mpv
03/15/2000CN1050353C Process for prepn. of alkylimidazolidone (meth)-acrylates
03/14/2000US6037157 Method for improving pharmacokinetics
03/14/2000CA2009542C Cyclic guanidines as calcium antagonists
03/08/2000CN1246850A 1,5-benzodiazepine derivatives
03/02/2000WO2000010942A1 Solid phase synthesis of compounds by carbon-carbon bond forming mitsunobu reactions
03/02/2000CA2338563A1 Solid phase synthesis of compounds by carbon-carbon bond forming mitsunobu reactions
03/01/2000CN1246157A Enzymatic resolution of benzodiazepine-acetic acid esters with lipase
02/2000
02/24/2000WO2000009480A1 Novel sulfonyl derivatives
02/24/2000CA2340100A1 Novel sulfonyl derivatives
02/22/2000CA2157248C Crystalline form of dihydro-2, 3 benzodiazepine derivative
02/17/2000WO2000007995A1 SUCCINOYLAMINO LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION
02/17/2000WO2000007980A1 Amide derivatives which are useful as cytokine inhibitors
02/17/2000CA2338944A1 Succinoylamino lactams as inhibitors of a.beta. protein production
02/16/2000EP0979227A1 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
02/10/2000WO2000006620A2 Polymerization of olefins
02/10/2000CA2338686A1 Polymerization of olefins
02/09/2000CN1049217C 1,5-benzodiazepine derivatives
02/08/2000US6022969 Symmetrical bis(aminoalkyl), bis(amidinoalkyl) and bis(guanidinoalkyl) cycloalkanes
02/03/2000WO2000004892A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
02/03/2000CA2335062A1 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
02/02/2000EP0975625A1 SELECTIVE FACTOR Xa INHIBITORS
02/02/2000EP0975608A2 Halo-alkoxycarbonyl prodrugs
01/2000
01/27/2000WO2000004020A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
01/27/2000CA2337377A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
01/26/2000EP0973763A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
01/20/2000WO2000002851A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
01/19/2000CN1242007A Cycloalkyl, lactam lactone and related compounds as 'beta'-amyloid peptide release inhibitors
01/19/2000CN1048484C A process for preparing a composition containing benzoheterocycles
01/13/2000WO2000001376A2 Pharmaceutical compositions and their uses for treatment of demyelinating disorders
01/12/2000EP0693067B1 Fibrinogen receptor antagonists
01/06/2000WO2000000479A1 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors
01/06/2000WO2000000202A1 Method for inhibiting c-jun expression using jak-3 inhibitors
01/06/2000CA2337999A1 Method for inhibiting c-jun expression using jak-3 inhibitors
01/06/2000CA2330110A1 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors
01/05/2000EP0968198A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR INHIBITING $g(b)-AMYLOID PEPTIDE
01/04/2000US6011045 Inhibitors of bone resorption; anticancer agents
01/04/2000US6011029 Benzodiazepine compounds
12/1999
12/29/1999WO1999067221A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999WO1999067220A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999WO1999067219A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999WO1999066934A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
12/29/1999EP0966449A1 Novel 1,4-diazacycloheptane derivatives and their use in hair oxidation dyes
12/29/1999CA2325389A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999CA2325388A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999CA2324475A1 Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
12/29/1999CA2324474A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/28/1999US6008216 Process for preparing 2-methyl-thieno-benzodiazepine
12/28/1999US6008214 Inhibiting platelet aggregation and bone resorption, treating stroke, transient ischemia attacks, or myocardial infarction, treating osteoporosis
12/23/1999WO1999065870A2 Sulfonamide inhibitors of aspartyl protease
12/22/1999EP0964928A1 Enzymatic resolution of benzodiazepine-acetic acid esters with a lipase
12/16/1999WO1999064403A1 1,5-benzodiazepine derivatives
12/16/1999CA2334798A1 1,5-benzodiazepine derivatives
12/15/1999CN1238689A Vitronectin receptor antagonists
12/14/1999US6001579 Supports and combinatorial chemical libraries thereof encoded by non-sequencable tags
12/08/1999CN1237961A Aminoguanidines and alkoxyguanidines as protease inhibitors
12/07/1999US5998614 Preparation of asymmetric cyclic ureas using an alkali metal in liquid ammonia process
12/07/1999US5998414 Troponyl piperazines as dopamine D4 receptor ligands
12/07/1999US5998407 Inhibitors of farnesyl-protein transferase
12/07/1999US5998406 Bactericides
12/07/1999CA2013037C Aminobenzenesulfonic acid derivative
12/01/1999EP0960104A1 N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors
11/1999
11/25/1999WO1999059977A1 Substituted 1,3-diaza-2-(thi)oxo-cycloalkanes
11/25/1999DE19822678A1 New 1,3-diaza-2-oxo-cycloalkane derivatives, useful as pre- or post-emergence, total or selective herbicides
11/25/1999CA2332443A1 Substituted 1,3-diaza-2-(thi)oxo-cycloalkanes
11/24/1999EP0957917A1 Vitronectin receptor antagonists
11/23/1999US5990145 Antiinflammatory,-carcinogenic,-tumor,-metastasis agents; cardiovascular disorders, e.g., arteriosclerosis, restenosis; retinopaathies and nephropathies; osteoporosis
11/23/1999US5990113 Monohydrate of 2-(1-piperazinyl)-5-methylbenzenesulfonic acid, free of anhydrous crystals; free from weight change due to moisture absorption and can be weighed accurately in manufacturing a pharmaceutical composition for heart diseases
11/17/1999CN1235602A 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic urea useful as HIV protease inhibitors
11/17/1999CN1046501C Thiourea compositions and preparation of nitryl, aromatic and imino heterocyclic compounds
11/16/1999US5986114 Benzopyranol derivatives
11/16/1999US5985869 Benzoheterocyclic compounds
11/16/1999CA2120215C 2,3-dihydro-4(1h)-quinazolinones active in gastro-intestinal pathologies
11/10/1999EP0776208B1 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines
11/04/1999WO1999055684A1 Solid supported synthesis of sulfonated 2-oxopiperazines
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 60